Orion Pharma Limited announced earnings results for the third quarter ended March 31, 2019. For the third quarter, the company announced sales was BDT 1,231.522 million compared to BDT 2,548.757 million a year ago. Operating income was BDT 410.466 million compared to BDT 366.367 million a year ago. Net income was BDT 221.831 million compared to BDT 160.351 million a year ago. Basic earnings per share was BDT 0.95 compared to BDT 0.69 a year ago. For the nine months, sales was BDT 6,712.713 million compared to BDT 7,650.642 million a year ago. Operating income was BDT 1,241.301 million compared to BDT 1,255.338 million a year ago. Net income was BDT 703.188 million compared to BDT 645.865 million a year ago. Basic earnings per share was BDT 3.01 compared to BDT 2.76 a year ago.